142 related articles for article (PubMed ID: 15380190)
1. Discovery of picomolar slow tight-binding inhibitors of alpha-fucosidase.
Chang CF; Ho CW; Wu CY; Chao TA; Wong CH; Lin CH
Chem Biol; 2004 Sep; 11(9):1301-6. PubMed ID: 15380190
[TBL] [Abstract][Full Text] [Related]
2. Discovery of different types of inhibition between the human and thermotoga maritima alpha-fucosidases by fuconojirimycin-based derivatives.
Ho CW; Lin YN; Chang CF; Li ST; Wu YT; Wu CY; Chang CF; Liu SW; Li YK; Lin CH
Biochemistry; 2006 May; 45(18):5695-702. PubMed ID: 16669613
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric synthesis of the L-fuco-nojirimycin, a nanomolar alpha-L-fucosidase inhibitor.
Dubernet M; Defoin A; Tarnus C
Bioorg Med Chem Lett; 2006 Mar; 16(5):1172-4. PubMed ID: 16376079
[TBL] [Abstract][Full Text] [Related]
4. Rapid diversity-oriented synthesis in microtiter plates for in situ screening: discovery of potent and selective alpha-fucosidase inhibitors.
Wu CY; Chang CF; Chen JS; Wong CH; Lin CH
Angew Chem Int Ed Engl; 2003 Oct; 42(38):4661-4. PubMed ID: 14533157
[No Abstract] [Full Text] [Related]
5. Structural basis of alpha-fucosidase inhibition by iminocyclitols with K(i) values in the micro- to picomolar range.
Wu HJ; Ho CW; Ko TP; Popat SD; Lin CH; Wang AH
Angew Chem Int Ed Engl; 2010; 49(2):337-40. PubMed ID: 19967696
[No Abstract] [Full Text] [Related]
6. Biological properties of D- and L-1-deoxyazasugars.
Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
[TBL] [Abstract][Full Text] [Related]
7. Glycosidase-substrate interactions analysis by STD-NMR spectroscopy: study of alpha-L-fucosidase.
Berteau O; Sandström C; Bielicki J; Anson DS; Kenne L
J Am Chem Soc; 2003 Dec; 125(50):15296-7. PubMed ID: 14664566
[TBL] [Abstract][Full Text] [Related]
8. Slow-binding inhibition of gamma-aminobutyric acid aminotransferase by hydrazine analogues.
Lightcap ES; Silverman RB
J Med Chem; 1996 Feb; 39(3):686-94. PubMed ID: 8576911
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of all-cis 2,5-imino-2,5-dideoxy-fucitol and its evaluation as a potent fucosidase and galactosidase inhibitor.
Ak A; Prudent S; LeNouën D; Defoin A; Tarnus C
Bioorg Med Chem Lett; 2010 Dec; 20(24):7410-3. PubMed ID: 21050758
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of alpha-L-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin.
Winchester B; Barker C; Baines S; Jacob GS; Namgoong SK; Fleet G
Biochem J; 1990 Jan; 265(1):277-82. PubMed ID: 2137330
[TBL] [Abstract][Full Text] [Related]
11. Rapid discovery of potent sulfotransferase inhibitors by diversity-oriented reaction in microplates followed by in situ screening.
Best MD; Brik A; Chapman E; Lee LV; Cheng WC; Wong CH
Chembiochem; 2004 Jun; 5(6):811-9. PubMed ID: 15174164
[TBL] [Abstract][Full Text] [Related]
12. Expeditious synthesis of tri- and tetrahydroxyazepanes from D-(-)-quinic acid as potent glycosidase inhibitors.
Shih TL; Yang RY; Li ST; Chiang CF; Lin CH
J Org Chem; 2007 May; 72(11):4258-61. PubMed ID: 17480095
[TBL] [Abstract][Full Text] [Related]
13. Three dimensional structure of a bacterial α-l-fucosidase with a 5-membered iminocyclitol inhibitor.
Wright DW; Moreno-Vargas AJ; Carmona AT; Robina I; Davies GJ
Bioorg Med Chem; 2013 Aug; 21(16):4751-4. PubMed ID: 23830696
[TBL] [Abstract][Full Text] [Related]
14. Exploiting the hydrophobic terrain in fucosidases with aryl-substituted pyrrolidine iminosugars.
Hottin A; Wright DW; Davies GJ; Behr JB
Chembiochem; 2015 Jan; 16(2):277-83. PubMed ID: 25427942
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective synthesis of (2S,3S,4R,5S)-5-methylpyrrolidine-3,4-diol derivatives that are highly selective alpha-L-fucosidase inhibitors.
Moreno-Vargas AJ; Carmona AT; Mora F; Vogel P; Robina I
Chem Commun (Camb); 2005 Oct; (39):4949-51. PubMed ID: 16205810
[TBL] [Abstract][Full Text] [Related]
16. Development of fucosyltransferase and fucosidase inhibitors.
Tu Z; Lin YN; Lin CH
Chem Soc Rev; 2013 May; 42(10):4459-75. PubMed ID: 23588106
[TBL] [Abstract][Full Text] [Related]
17. Microtiter plate based chemistry and in situ screening: a useful approach for rapid inhibitor discovery.
Brik A; Wu CY; Wong CH
Org Biomol Chem; 2006 Apr; 4(8):1446-57. PubMed ID: 16604207
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-(2-fluorophenyl)-2β-deoxyfuconojirimycin acetamide as a potent inhibitor for α-l-fucosidases.
Kato A; Okaki T; Ifuku S; Sato K; Hirokami Y; Iwaki R; Kamori A; Nakagawa S; Adachi I; Kiria PG; Onomura O; Minato D; Sugimoto K; Matsuya Y; Toyooka N
Bioorg Med Chem; 2013 Nov; 21(21):6565-73. PubMed ID: 24026016
[TBL] [Abstract][Full Text] [Related]
19. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.
Ali A; Reddy GS; Cao H; Anjum SG; Nalam MN; Schiffer CA; Rana TM
J Med Chem; 2006 Dec; 49(25):7342-56. PubMed ID: 17149864
[TBL] [Abstract][Full Text] [Related]
20. Nucleophilic opening of epoxyazepanes: expanding the family of polyhydroxyazepane-based glycosidase inhibitors.
Li H; Schütz C; Favre S; Zhang Y; Vogel P; Sinaÿ P; Blériot Y
Org Biomol Chem; 2006 May; 4(9):1653-62. PubMed ID: 16633556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
